Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevasiranib in Diabetic Macular Edema
NCT00306904Phase 2Completed
- Sponsor
- OPKO Health
- Start
- Jan 2006
- Primary completion
- Sep 2007
- Countries
- 1
01
Overview
A Phase 2 trial of bevasiranib in diabetic macular edema (DME), sponsored by OPKO Health. Started Jan 2006; status: completed.
02
Drugs
bevasiranib
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00306904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306904.